Cargando…
The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma
Salivary duct carcinoma (SDC) is an aggressive, uncommon tumor histologically comparable to high-grade mammary ductal carcinoma. SDCs are usually androgen receptor (AR)–positive and often HER2-positive. Recently, therapies targeting these molecules for SDC have attracted attention. Lipid metabolism...
Autores principales: | Hirai, Hideaki, Tada, Yuichiro, Nakaguro, Masato, Kawakita, Daisuke, Sato, Yukiko, Shimura, Tomotaka, Tsukahara, Kiyoaki, Kano, Satoshi, Ozawa, Hiroyuki, Okami, Kenji, Sato, Yuichiro, Fushimi, Chihiro, Shimizu, Akira, Okamoto, Isaku, Takase, Soichiro, Okada, Takuro, Sato, Hiroki, Imanishi, Yorihisa, Otsuka, Kuninori, Watanabe, Yoshihiro, Sakai, Akihiro, Ebisumoto, Koji, Togashi, Takafumi, Ueki, Yushi, Ota, Hisayuki, Saigusa, Natsuki, Takahashi, Hideaki, Ando, Mizuo, Urano, Makoto, Hanazawa, Toyoyuki, Nagao, Toshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371671/ https://www.ncbi.nlm.nih.gov/pubmed/32103349 http://dx.doi.org/10.1007/s00428-020-02777-w |
Ejemplares similares
-
Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas
por: Shimura, Tomotaka, et al.
Publicado: (2017) -
Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification
por: Takase, Soichiro, et al.
Publicado: (2017) -
The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy
por: Saigusa, Natsuki, et al.
Publicado: (2022) -
Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan
por: Kawakita, Daisuke, et al.
Publicado: (2016) -
Survival benefit of HER2-targeted or androgen deprivation therapy in
salivary duct carcinoma
por: Kawakita, Daisuke, et al.
Publicado: (2022)